PPAR-γ has significant contribution in case of inflammatory response regulation; therefore anti-inflammatory property containing drugs, which has the ability to play a role as a PPAR-γ agonist, can cause suppression of the pro-inflammatory actions of Aβ in AD (Heneka et al., 2011). The gene discussed is PPARG; the disease is Alzheimer disease.